Antibody fragment (linker, curved)

[{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e20c405e91300bc0bb8/5c264de5c405e91300bc0baa.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e20c405e91300bc0bb8/5c264de5c405e91300bc0baa.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e20c405e91300bc0bb7/5c264de5c405e91300bc0baa.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e20c405e91300bc0bb7/5c264de5c405e91300bc0baa.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e20c405e91300bc0bb6/5c264de5c405e91300bc0baa.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e20c405e91300bc0bb6/5c264de5c405e91300bc0baa.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e20c405e91300bc0bb5/5c264de5c405e91300bc0baa.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e20c405e91300bc0bb5/5c264de5c405e91300bc0baa.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e20c405e91300bc0bb4/5c264de5c405e91300bc0baa.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e20c405e91300bc0bb4/5c264de5c405e91300bc0baa.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e20c405e91300bc0bb3/5c264de5c405e91300bc0baa.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e20c405e91300bc0bb3/5c264de5c405e91300bc0baa.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e20c405e91300bc0bb2/5c264de5c405e91300bc0baa.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e20c405e91300bc0bb2/5c264de5c405e91300bc0baa.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e20c405e91300bc0bb1/5c264de5c405e91300bc0baa.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e20c405e91300bc0bb1/5c264de5c405e91300bc0baa.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e20c405e91300bc0bb0/5c264de5c405e91300bc0baa.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e20c405e91300bc0bb0/5c264de5c405e91300bc0baa.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e20c405e91300bc0baf/5c264de5c405e91300bc0baa.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e20c405e91300bc0baf/5c264de5c405e91300bc0baa.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e20c405e91300bc0bae/5c264de5c405e91300bc0baa.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e20c405e91300bc0bae/5c264de5c405e91300bc0baa.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e20c405e91300bc0bad/5c264de5c405e91300bc0baa.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e20c405e91300bc0bad/5c264de5c405e91300bc0baa.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e20c405e91300bc0bac/5c264de5c405e91300bc0baa.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e20c405e91300bc0bac/5c264de5c405e91300bc0baa.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e20c405e91300bc0bab/5c264de5c405e91300bc0baa.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e20c405e91300bc0bab/5c264de5c405e91300bc0baa.png"}]